Harmeier returns to lead Roche Venture Fund

Roche Venture Fund has chosen Anja Harmeier to succeed Carole Nuechterlein as head of the fund. Harmeier is returning after nearly six years away from RVF; she had held roles including investment director and investment manager before departing in 2020. In between, Harmeier was a partner at BB Pureos Bioventures until the summer of 2021; she had been CEO of Rewind Therapeutics N.V. since then. Nuechterlein, who spent 25 years with RVF, said in June she planned to retire in spring 2026.

Eisai Co. Ltd. (Tokyo:4523) promoted Takuyo Oyama to VP and CFO, replacing the retiring Mitsuru Shomon. Oyama had been a senior group officer and special associate of the company’s CBO...